FDA Approved: BESIVANCE — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BESIVANCE (besifloxacin) from Bausch & Lomb Americas Inc., resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• BESIVANCE (besifloxacin)

Snippet

SUPPL AP for BESIVANCE (BESIFLOXACIN)